Entegrion, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.entegrion.com
Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired Coagulopathy
Phase 2
Terminated
- Conditions
- Coagulopathy
- Interventions
- Biological: ResusixBiological: FP24 (Frozen Plasma)
- First Posted Date
- 2018-10-09
- Last Posted Date
- 2021-01-07
- Lead Sponsor
- Entegrion, Inc.
- Target Recruit Count
- 4
- Registration Number
- NCT03700723
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
🇺🇸Carolinas Medical Center, Charlotte, North Carolina, United States
🇺🇸Washington University St. Louis, Saint Louis, Missouri, United States
Comparative Analysis of PCM With ROTEM in the Measurement of Viscoelastic Coagulation Parameters
- Conditions
- Hemostasis Monitoring
- Interventions
- Device: PCM and ROTEM
- First Posted Date
- 2018-09-20
- Last Posted Date
- 2020-04-16
- Lead Sponsor
- Entegrion, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT03679286
- Locations
- 🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸Washington University in St. Louis, Saint Louis, Missouri, United States
🇺🇸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Reference Range Analysis of the Entegrion Point of Care Coagulation Monitor (PCM™) in Healthy Volunteers
- Conditions
- Coagulation
- Interventions
- Device: PCM
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2020-04-16
- Lead Sponsor
- Entegrion, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT03133351
- Locations
- 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
🇺🇸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers
Phase 1
Completed
- Conditions
- Coagulation Defects
- Interventions
- Drug: Spray-dried S/D-treated plasma
- First Posted Date
- 2012-05-02
- Last Posted Date
- 2017-02-07
- Lead Sponsor
- Entegrion, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT01589666
- Locations
- 🇺🇸
Vince & Associates Clinical Research, Overland Park, Kansas, United States
© Copyright 2025. All Rights Reserved by MedPath